Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025)

Siga Technologies (SIGA) posted Liabilities and Shareholders Equity of $219.5 million for Q4 2025, down 5.24% on a QoQ basis from $231.6 million in Q3 2025, and down 10.18% year-over-year from $244.3 million in Q4 2024.

Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends

Siga Technologies' Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $219.5 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 10.18% year-over-year to $219.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $933.5 million (up 6.62% YoY) and the FY2025 annual result came in at $219.5 million, down 10.18% from the prior year.
  • Liabilities and Shareholders Equity was $219.5 million for Q4 2025 at Siga Technologies, down from $231.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $254.4 million in Q4 2023 and bottomed at $133.7 million in Q2 2021.
  • A 5-year average of $195.9 million and a median of $195.2 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 50.65% — and 2023, when it slipped 22.45%.
  • Siga Technologies' Liabilities and Shareholders Equity stood at $214.7 million in 2021, then retreated by 9.17% to $195.0 million in 2022, then jumped by 30.41% to $254.4 million in 2023, then declined by 3.94% to $244.3 million in 2024, then retreated by 10.18% to $219.5 million in 2025.
  • Business Quant data shows SIGA's Liabilities and Shareholders Equity at $219.5 million in Q4 2025, $231.6 million in Q3 2025, and $235.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Siga Technologies 225.56 Mn 70.59 Mn - 219.47 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 219.47 Mn
Sep 30, 2025 231.60 Mn
Jun 30, 2025 235.33 Mn
Mar 31, 2025 247.07 Mn
Dec 31, 2024 244.34 Mn
Sep 30, 2024 195.35 Mn
Jun 30, 2024 192.66 Mn
Mar 31, 2024 243.15 Mn
Dec 31, 2023 254.35 Mn
Sep 30, 2023 158.38 Mn
Jun 30, 2023 146.51 Mn
Mar 31, 2023 183.92 Mn
Dec 31, 2022 195.04 Mn
Sep 30, 2022 204.22 Mn
Jun 30, 2022 159.94 Mn
Mar 31, 2022 184.55 Mn
Dec 31, 2021 214.73 Mn
Sep 30, 2021 135.56 Mn
Jun 30, 2021 133.69 Mn
Mar 31, 2021 138.77 Mn